Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$80.93 - $108.63 $1.38 Million - $1.85 Million
-17,020 Reduced 36.17%
30,040 $3.11 Million
Q3 2022

Nov 18, 2022

BUY
$82.16 - $96.94 $166,784 - $196,788
2,030 Added 4.51%
47,060 $3.99 Million
Q2 2022

Aug 10, 2022

SELL
$71.48 - $86.85 $389,566 - $473,332
-5,450 Reduced 10.8%
45,030 $3.73 Million
Q1 2022

May 13, 2022

BUY
$74.28 - $92.69 $3.75 Million - $4.68 Million
50,480 New
50,480 $3.9 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Industrial Alliance Investment Management Inc. Portfolio

Follow Industrial Alliance Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Industrial Alliance Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Industrial Alliance Investment Management Inc. with notifications on news.